These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20339854)

  • 1. Loss of cell-surface receptor EphB2 is important for the growth, migration, and invasiveness of a colon cancer cell line.
    Senior PV; Zhang BX; Chan ST
    Int J Colorectal Dis; 2010 Jun; 25(6):687-94. PubMed ID: 20339854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase.
    Wang SD; Rath P; Lal B; Richard JP; Li Y; Goodwin CR; Laterra J; Xia S
    Oncogene; 2012 Dec; 31(50):5132-43. PubMed ID: 22310282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.
    Guo DL; Zhang J; Yuen ST; Tsui WY; Chan AS; Ho C; Ji J; Leung SY; Chen X
    Carcinogenesis; 2006 Mar; 27(3):454-64. PubMed ID: 16272170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells.
    Nakada M; Niska JA; Miyamori H; McDonough WS; Wu J; Sato H; Berens ME
    Cancer Res; 2004 May; 64(9):3179-85. PubMed ID: 15126357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoted cancer growth by stimulating cell proliferation and decreasing apoptosis using a lentivirus-based EphB2 RNAi in pancreatic carcinoma CFPAC-1 cells.
    Hua YQ; Ouyang HQ; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Liu LM
    Biomed Pharmacother; 2011 Mar; 65(2):123-31. PubMed ID: 21292437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma.
    Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Toriseva M; Kivisaari A; Ala-Aho R; Kallajoki M; Veräjänkorva E; Honkanen HK; Heljasvaara R; Pihlajaniemi T; Grénman R; Peltonen J; Peltonen S; Kähäri VM
    J Invest Dermatol; 2015 Jul; 135(7):1882-1892. PubMed ID: 25789706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo.
    Cheng B; Wang Q; Song Y; Liu Y; Liu Y; Yang S; Li D; Zhang Y; Zhu C
    Sci Rep; 2020 Apr; 10(1):6741. PubMed ID: 32317702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of EPH receptor B2 in malignant mesothelioma correlates with oncogenic behavior.
    Goparaju C; Donington JS; Hsu T; Harrington R; Hirsch N; Pass HI
    J Thorac Oncol; 2013 Sep; 8(9):1203-11. PubMed ID: 23887168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EphrinB1 promotes cancer cell migration and invasion through the interaction with RhoGDI1.
    Cho HJ; Hwang YS; Yoon J; Lee M; Lee HG; Daar IO
    Oncogene; 2018 Feb; 37(7):861-872. PubMed ID: 29059157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EphB2 as a therapeutic antibody drug target for the treatment of colorectal cancer.
    Mao W; Luis E; Ross S; Silva J; Tan C; Crowley C; Chui C; Franz G; Senter P; Koeppen H; Polakis P
    Cancer Res; 2004 Feb; 64(3):781-8. PubMed ID: 14871799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between the EPHB2 receptor and EFNB1 ligand drives gastric cancer invasion and metastasis via the Wnt/β-catenin/FAK pathway.
    Hu Y; Xie Q; Zhao J; Yang R; Qin J; Li H; Zhao Y; Du X; Shi C
    Int J Biol Macromol; 2024 Feb; 258(Pt 1):128848. PubMed ID: 38114003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sesamin induces autophagy in colon cancer cells by reducing tyrosine phosphorylation of EphA1 and EphB2.
    Tanabe H; Kuribayashi K; Tsuji N; Tanaka M; Kobayashi D; Watanabe N
    Int J Oncol; 2011 Jul; 39(1):33-40. PubMed ID: 21503576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butyrate regulates the expression of c-Src and focal adhesion kinase and inhibits cell invasion of human colon cancer cells.
    Lee JC; Maa MC; Yu HS; Wang JH; Yen CK; Wang ST; Chen YJ; Liu Y; Jin YT; Leu TH
    Mol Carcinog; 2005 Aug; 43(4):207-14. PubMed ID: 16001424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of EphB2 activation and cell repulsion by feedback control of the MAPK pathway.
    Poliakov A; Cotrina ML; Pasini A; Wilkinson DG
    J Cell Biol; 2008 Dec; 183(5):933-47. PubMed ID: 19047466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion.
    Nakada M; Niska JA; Tran NL; McDonough WS; Berens ME
    Am J Pathol; 2005 Aug; 167(2):565-76. PubMed ID: 16049340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wild-type p53 inhibits pro-invasive properties of TGF-β3 in breast cancer, in part through regulation of EPHB2, a new TGF-β target gene.
    Lam S; Wiercinska E; Teunisse AF; Lodder K; ten Dijke P; Jochemsen AG
    Breast Cancer Res Treat; 2014 Nov; 148(1):7-18. PubMed ID: 25257729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells.
    Song ZY; Gao ZH; Chu JH; Han XZ; Qu XJ
    Biomed Pharmacother; 2015 Apr; 71():46-52. PubMed ID: 25960214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological blockade of aquaporin-1 water channel by AqB013 restricts migration and invasiveness of colon cancer cells and prevents endothelial tube formation in vitro.
    Dorward HS; Du A; Bruhn MA; Wrin J; Pei JV; Evdokiou A; Price TJ; Yool AJ; Hardingham JE
    J Exp Clin Cancer Res; 2016 Feb; 35():36. PubMed ID: 26912239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of
    Ma WR; Xu P; Liu ZJ; Zhou J; Gu LK; Zhang J; Deng DJ
    World J Gastroenterol; 2020 Jan; 26(2):184-198. PubMed ID: 31988584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.